BKBG
DGX icon

BHF Kleinwort Benson Group’s Quest Diagnostics DGX Stock Holding History

BHF Kleinwort Benson Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$210K Buy
+2,945
New +$198K 0.01% 352
2015
Q4 		– Sell
-3,460
Closed -$213K – 412
2015
Q3 		$213K Buy
+3,460
New +$242K 0.01% 335

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BHF Kleinwort Benson Group's DGX Position: Q1 2016 in Review

BHF Kleinwort Benson Group opened a new position in Quest Diagnostics (DGX) in Q1 2016: 2,945 shares worth $210K. The stake represents 0.01% of the portfolio and ranks #352 among its holdings. This is a return to the name: BHF Kleinwort Benson Group previously reported a position in DGX as recently as Q3 2015.

BHF Kleinwort Benson Group first reported a position in DGX in Q3 2015 and has held it in 2 quarters since. The position peaked at $213K in Q3 2015. 557 funds tracked by Wall St. Rank hold DGX as of Q1 2016.

  • BHF Kleinwort Benson Group held 2,945 shares of Quest Diagnostics worth $210K as of Q1 2016.
  • Quest Diagnostics was a new BHF Kleinwort Benson Group position in Q1 2016.
  • Quest Diagnostics made up 0.01% of BHF Kleinwort Benson Group's portfolio in Q1 2016, its #352 holding.
  • BHF Kleinwort Benson Group first reported a position in Quest Diagnostics in Q3 2015 and has held it in 2 quarters since.
  • BHF Kleinwort Benson Group's Quest Diagnostics position peaked at $213K in Q3 2015.
  • 557 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2016.

Based on BHF Kleinwort Benson Group's 13F filing for Q1 2016, filed 9 May 2016.